Australia's most trusted
source of pharma news
Friday, 14 February 2025
Posted 7 June 2024 AM
Three companies have begun the process to gain government subsidy for their cancer drugs ahead of TGA approval, an update from the Medical Services Advisory Committee (MSAC) shows.
Certain tests to determine eligibility for Taiho Pharma's Lytgobi, A Menarini's Orserdu, and Roche's inavolisib on the PBS have been scheduled for MSAC's PICO Advisory Sub Committee's (PASC) meeting in August 2024.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.